There are no benefits to treating patients with hydroxychloroquine after they have already been exposed to COVID-19, according to a new study published in the New England Journal of Medicine.
A large coalition, including several cardiology groups, is asking Congress to pass legislation that would help protect healthcare providers from the final rule's "arbitrary" Medicare cuts.